The association between new and established cardiovascular serum markers

Completed

• Conditions: Cardiovascular disease; Circulatory System; Complications and ill-defined descriptions of heart disease

• Registration Number: ISRCTN79274394
• Lead Sponsor: niversity Hospital Maastricht (AZM) (The Netherlands)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2005-12-19
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 120

Inclusion Criteria

Groups of acute myocardial infarction (AMI), stable angina pectoris (SAP), unstable angina pectoris (UAP) and controls will be formed (n = 120). All participants will donate a venous blood sample at inclusion, and after 6 and 12 months. Marker concentration will be evaluated in these blood samples.

Exclusion Criteria

1. Unable to give informed consent
2. Cardiovascular disease (CVD) less than 6 months
3. Auto-immune diseases
4. Malignancies
5. Renal insufficiency (less than 40 ml/min creatinine clearance)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
(Recurrent) cardiovascular disease e.g. myocardial infarction (MI), SAP, UAP, mortality

Secondary Outcome Measures

Name	Time	Method
o secondary outcome measures